JP2002539772A5 - - Google Patents

Download PDF

Info

Publication number
JP2002539772A5
JP2002539772A5 JP2000601126A JP2000601126A JP2002539772A5 JP 2002539772 A5 JP2002539772 A5 JP 2002539772A5 JP 2000601126 A JP2000601126 A JP 2000601126A JP 2000601126 A JP2000601126 A JP 2000601126A JP 2002539772 A5 JP2002539772 A5 JP 2002539772A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000601126A
Other languages
Japanese (ja)
Other versions
JP2002539772A (ja
Filing date
Publication date
Priority claimed from US09/387,699 external-priority patent/US6221660B1/en
Application filed filed Critical
Publication of JP2002539772A publication Critical patent/JP2002539772A/ja
Publication of JP2002539772A5 publication Critical patent/JP2002539772A5/ja
Withdrawn legal-status Critical Current

Links

JP2000601126A 1999-02-22 2000-02-22 Ｓｎｏｒｆ２５受容体をコードするｄｎａ Withdrawn JP2002539772A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25537699A 1999-02-22 1999-02-22
US09/387,699 US6221660B1 (en) 1999-02-22 1999-08-13 DNA encoding SNORF25 receptor
US09/387,699 1999-08-13
US09/255,376 1999-08-13
PCT/US2000/004413 WO2000050562A2 (en) 1999-02-22 2000-02-22 Dna encoding snorf25 receptor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009212252A Division JP2010063457A (ja) 1999-02-22 2009-09-14 Ｓｎｏｒｆ２５受容体をコードするｄｎａ

Publications (2)

Publication Number Publication Date
JP2002539772A JP2002539772A (ja) 2002-11-26
JP2002539772A5 true JP2002539772A5 (enExample) 2005-12-22

Family

ID=26944658

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000601126A Withdrawn JP2002539772A (ja) 1999-02-22 2000-02-22 Ｓｎｏｒｆ２５受容体をコードするｄｎａ
JP2009212252A Withdrawn JP2010063457A (ja) 1999-02-22 2009-09-14 Ｓｎｏｒｆ２５受容体をコードするｄｎａ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009212252A Withdrawn JP2010063457A (ja) 1999-02-22 2009-09-14 Ｓｎｏｒｆ２５受容体をコードするｄｎａ

Country Status (12)

Country Link
US (3) US6221660B1 (enExample)
EP (1) EP1075493B1 (enExample)
JP (2) JP2002539772A (enExample)
AT (1) ATE405589T1 (enExample)
AU (1) AU777247B2 (enExample)
CA (1) CA2362906A1 (enExample)
CY (1) CY1108503T1 (enExample)
DE (1) DE60039948D1 (enExample)
DK (1) DK1075493T3 (enExample)
ES (1) ES2312333T3 (enExample)
PT (1) PT1075493E (enExample)
WO (1) WO2000050562A2 (enExample)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816492B2 (en) * 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US20030017528A1 (en) * 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
KR20080104062A (ko) * 1998-11-20 2008-11-28 아레나 파마슈티칼스, 인크. 사람의 오르판 ｇ 단백질 커플링 수용체
US20030125539A1 (en) * 1999-02-22 2003-07-03 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US6987005B1 (en) 1999-05-28 2006-01-17 H. Lundbeck A/S DNA encoding SNORF33 receptor
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
WO2001032864A2 (en) * 1999-11-03 2001-05-10 Merck Patent Gmbh Gpcr-kd5 polypeptides and dna sequences thereof
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
ATE348162T1 (de) * 2000-05-18 2007-01-15 Bayer Healthcare Ag Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor.
DE60125227T2 (de) * 2000-12-01 2007-09-20 Astellas Pharma Inc. Verfahren zum screening von diabetes-heilverfahren
US20030064381A1 (en) * 2001-03-07 2003-04-03 Feder John N. Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY26, expressed highly in testis and gastrointestinal tissues
US20030045685A1 (en) * 2001-03-09 2003-03-06 Tularik Inc. Novel receptors
US7053121B2 (en) * 2001-03-19 2006-05-30 Trustees Of The University Of Pennsylvania Compositions and methods for regulating circadian rhythms
EP1487965A4 (en) 2002-02-25 2006-11-15 Mpex Pharmaceuticals Inc MINI COMPOSITIONS AND METHODS
CA2489405A1 (en) * 2002-09-11 2004-03-25 Yamanouchi Pharmaceutical Co., Ltd. Screening method of agents for increasing insulin content
US20030143590A1 (en) * 2002-11-18 2003-07-31 Shyam Ramakrishnan Regulation of human dopamine-like g protein- coupled receptor
WO2004099419A2 (en) * 2003-04-30 2004-11-18 Arena Pharmaceuticals, Inc. Methods and compositions for identifying modulators of g protein-coupled receptors
US7083933B1 (en) * 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
CA2525286C (en) * 2003-05-20 2012-09-11 The University Court Of The University Of Glasgow Materials and methods relating to g-protein coupled receptor oligomers
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
NZ556017A (en) * 2004-12-24 2009-10-30 Prosidion Ltd G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
DOP2006000008A (es) 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
US7306203B2 (en) * 2005-01-28 2007-12-11 Platt Robert E Post assembly and spacer for use therewith
WO2006113236A2 (en) * 2005-04-14 2006-10-26 Cornell Research Foundation, Inc. Novel chemical inhibitors of neutrophil activation through the sac-dependent pathway
EP2308840A1 (en) 2005-06-30 2011-04-13 Prosidion Limited GPCR agonists
JP5114395B2 (ja) * 2005-06-30 2013-01-09 プロシディオン・リミテッド Ｇｐｃｒアゴニスト
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
BRPI0710597A2 (pt) * 2006-04-11 2012-06-19 Arena Pharm Inc método de uso do receptor gpr119 para identificar compostos úteis para aumento da massa óssea em um indivìduo
US7638541B2 (en) * 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
PE20081849A1 (es) 2007-01-04 2009-01-26 Prosidion Ltd Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
ES2373181T3 (es) 2007-01-04 2012-02-01 Prosidion Ltd Agonistas de gpcr de piperidina.
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
AR064735A1 (es) * 2007-01-04 2009-04-22 Prosidion Ltd Agonistas de gpcr y composicion farmaceutica en base al compuesto
EP2114936A1 (en) 2007-01-04 2009-11-11 Prosidion Limited Piperidine gpcr agonists
CA2693169C (en) * 2007-07-19 2016-01-12 Metabolex, Inc. N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
EP2200609A1 (en) * 2007-09-10 2010-06-30 Prosidion Limited Compounds for the treatment of metabolic disorders
AU2008302570B2 (en) * 2007-09-20 2012-05-31 Irm Llc Compounds and compositions as modulators of GPR119 activity
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
TW201002705A (en) * 2008-03-31 2010-01-16 Metabolex Inc Oxymethylene aryl compounds and uses thereof
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
GB0812648D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
GB0812642D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
GB0812649D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
ES2387865T3 (es) * 2008-07-10 2012-10-03 Prosidion Ltd Agonistas de GPCR de piperidina
US20110160222A1 (en) * 2008-11-26 2011-06-30 Metabolex, Inc. Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
WO2010084512A1 (en) 2008-12-24 2010-07-29 Cadila Healthcare Limited Novel oxime derivatives
GB0904284D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904287D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904285D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
US20120094935A1 (en) * 2009-04-09 2012-04-19 West Anthony P Methods for creating or identifying compounds that bind tumor necrosis factor alpha
JP5538528B2 (ja) 2009-06-18 2014-07-02 カディラ・ヘルスケア・リミテッド 新規なｇｐｒ１１９アゴニスト
TW201113269A (en) * 2009-06-24 2011-04-16 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
NZ596445A (en) * 2009-06-24 2013-04-26 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
JP2012228180A (ja) * 2009-09-02 2012-11-22 Panasonic Corp 脂質二重膜の産生方法、化学物質を検知可能とする方法、細胞、カリウムイオンを輸送する方法、および化学物質を検知または定量する方法
JP2012228181A (ja) * 2009-09-02 2012-11-22 Panasonic Corp 脂質二重膜の産生方法、化学物質を検知可能とする方法、細胞、カリウムイオンを輸送する方法、および化学物質を検知または定量する方法
CN102666553B (zh) * 2009-10-01 2015-05-06 赛马拜制药公司 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐
GB201006166D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB201006167D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
TW201209054A (en) 2010-05-28 2012-03-01 Prosidion Ltd Novel compounds
ES2676209T3 (es) 2010-06-23 2018-07-17 Metabolex Inc. Composiciones de 5-etil-2-{4-[4-(4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
DK2625177T3 (en) 2010-10-08 2015-10-12 Cadila Healthcare Ltd New GPR 119 agonists
AR083904A1 (es) 2010-11-18 2013-04-10 Prosidion Ltd Derivados de 1,4-pirrolidinas disustituidos y 3-il-aminas y sus usos en el tratamiento de desordenes metabolicos
GB201114389D0 (en) 2011-08-22 2011-10-05 Prosidion Ltd Novel compounds
WO2012170867A1 (en) 2011-06-09 2012-12-13 Rhizen Pharmaceuticals Sa Novel compounds as modulators of gpr-119
JP2019527693A (ja) 2016-08-03 2019-10-03 サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 炎症性胃腸疾患または胃腸状態を治療するためのオキシメチレンアリール化合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053337A (en) 1989-10-30 1991-10-01 Neurogenetic Corporation DNA encoding an α2B -adrenergic receptor
US5661024A (en) 1989-10-31 1997-08-26 Synaptic Pharmaceutical Corporation DNA encoding a human serotonic (5-HT2) receptor and uses thereof
US5155218A (en) 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
EP0585415B1 (en) 1991-12-02 2005-03-30 Synaptic Pharmaceutical Corporation Dna encoding a human 5-ht 1e receptor and uses thereof
US5360735A (en) 1992-01-08 1994-11-01 Synaptic Pharmaceutical Corporation DNA encoding a human 5-HT1F receptor, vectors, and host cells
WO1993025677A1 (en) 1992-06-12 1993-12-23 Garvan Institute Of Medical Research DNA SEQUENCES ENCODING THE HUMAN A1, A2a and A2b ADENOSINE RECEPTORS
EP1063291A3 (en) 1992-09-25 2001-04-25 Synaptic Pharmaceutical Corporation DNA encoding human alpha 1 adrenergic receptors and uses thereof
US5472866A (en) 1992-12-24 1995-12-05 Synaptic Pharmaceutical Corporation DNA encoding 5-HT4A serotonin receptors
US5516653A (en) 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
WO2000022131A2 (en) 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
KR20080104062A (ko) 1998-11-20 2008-11-28 아레나 파마슈티칼스, 인크. 사람의 오르판 ｇ 단백질 커플링 수용체
US20030017528A1 (en) * 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US20040224314A1 (en) 1999-12-10 2004-11-11 Neil Burford G-protein coupled receptors

Similar Documents

Publication Publication Date Title
BE2014C035I2 (enExample)
BE2014C019I2 (enExample)
BE2014C009I2 (enExample)
BE2012C016I2 (enExample)
BE2010C009I2 (enExample)
BE2009C057I2 (enExample)
BE2011C032I2 (enExample)
BE2010C019I2 (enExample)
BE2010C018I2 (enExample)
BRPI0113085B8 (enExample)
JP2003516691A5 (enExample)
BRPI0112928B8 (enExample)
JP2002539772A5 (enExample)
JP2001306393A5 (enExample)
BE2010C040I2 (enExample)
JP2003503967A5 (enExample)
JP2001061828A5 (enExample)
JP2002118806A5 (enExample)
JP2003514645A5 (enExample)
JP2001219855A5 (enExample)
BR0112866A2 (enExample)
JP2001192159A5 (enExample)
JP2001299661A5 (enExample)
JP2001281769A5 (enExample)
AU2000273097A8 (enExample)